928063-59-6 Usage
General Description
2-(4-hydroxy-4-methylcyclohexyl)acetic acid is a chemical compound with the molecular formula C11H20O3. It is a derivative of cyclohexane and contains a carboxylic acid functional group. 2-(4-hydroxy-4-methylcyclohexyl)acetic acid is commonly used in the pharmaceutical industry as a starting material for the synthesis of various drugs and pharmaceutical products. Its structure and properties make it suitable for use as a building block in the synthesis of organic compounds. Additionally, the hydroxy and methyl groups on the cyclohexyl ring provide unique reactivity and selectivity in chemical reactions. Its potential applications also extend to the fields of chemistry and material science, making it a versatile and valuable chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 928063-59-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,8,0,6 and 3 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 928063-59:
(8*9)+(7*2)+(6*8)+(5*0)+(4*6)+(3*3)+(2*5)+(1*9)=186
186 % 10 = 6
So 928063-59-6 is a valid CAS Registry Number.
928063-59-6Relevant articles and documents
Inhibitors of Serine Proteases
-
, (2010/12/26)
The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.
DUAL MODULATORS OF 5HT2A AND D3 RECEPTORS
-
Page/Page column 45, (2009/02/11)
The present invention relates to compounds of the formula (I) wherein R1, R2, X and n are as defined in the specification as dual modulators of the serotonin 5-HT2a and dopamine D3 receptors, their manufacture,
